Cargando…

Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry

BACKGROUND: Men are at higher risk for serious complications related to COVID-19 infection than women. More robust immune activation in women has been proposed to contribute to decreased disease severity, although systemic inflammation has been associated with worse outcomes in COVID-19 infection. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Emily S., McNeill, Jenna N., Paniagua, Samantha M., Liu, Elizabeth E., Wang, Jessica K., Bassett, Ingrid V., Selvaggi, Caitlin A., Lubitz, Steven A., Foulkes, Andrea S., Ho, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081177/
https://www.ncbi.nlm.nih.gov/pubmed/33909684
http://dx.doi.org/10.1371/journal.pone.0250774
_version_ 1783685585524752384
author Lau, Emily S.
McNeill, Jenna N.
Paniagua, Samantha M.
Liu, Elizabeth E.
Wang, Jessica K.
Bassett, Ingrid V.
Selvaggi, Caitlin A.
Lubitz, Steven A.
Foulkes, Andrea S.
Ho, Jennifer E.
author_facet Lau, Emily S.
McNeill, Jenna N.
Paniagua, Samantha M.
Liu, Elizabeth E.
Wang, Jessica K.
Bassett, Ingrid V.
Selvaggi, Caitlin A.
Lubitz, Steven A.
Foulkes, Andrea S.
Ho, Jennifer E.
author_sort Lau, Emily S.
collection PubMed
description BACKGROUND: Men are at higher risk for serious complications related to COVID-19 infection than women. More robust immune activation in women has been proposed to contribute to decreased disease severity, although systemic inflammation has been associated with worse outcomes in COVID-19 infection. Whether systemic inflammation contributes to sex differences in COVID-19 infection is not known. STUDY DESIGN AND METHODS: We examined sex differences in inflammatory markers among 453 men (mean age 61) and 328 women (mean age 62) hospitalized with COVID-19 infection at the Massachusetts General Hospital from March 8 to April 27, 2020. Multivariable linear regression models were used to examine the association of sex with initial and peak inflammatory markers. Exploratory analyses examined the association of sex and inflammatory markers with 28-day clinical outcomes using multivariable logistic regression. RESULTS: Initial and peak CRP were higher in men compared with women after adjustment for baseline differences (initial CRP: ß 0.29, SE 0.07, p = 0.0001; peak CRP: ß 0.31, SE 0.07, p<0.0001) with similar findings for IL-6, PCT, and ferritin (p<0.05 for all). Men had greater than 1.5-greater odds of dying compared with women (OR 1.71, 95% CI 1.04–2.80, p = 0.03). Sex modified the association of peak CRP with both death and ICU admission, with stronger associations observed in men compared with women (death: OR 9.19, 95% CI 4.29–19.7, p <0.0001 in men vs OR 2.81, 95% CI 1.52–5.18, p = 0.009 in women, P(interaction) = 0.02). CONCLUSIONS: In a sample of 781 men and women hospitalized with COVID-19 infection, men exhibited more robust inflammatory activation as evidenced by higher initial and peak inflammatory markers, as well as worse clinical outcomes. Better understanding of sex differences in immune responses to COVID-19 infection may shed light on the pathophysiology of COVID-19 infection.
format Online
Article
Text
id pubmed-8081177
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-80811772021-05-06 Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry Lau, Emily S. McNeill, Jenna N. Paniagua, Samantha M. Liu, Elizabeth E. Wang, Jessica K. Bassett, Ingrid V. Selvaggi, Caitlin A. Lubitz, Steven A. Foulkes, Andrea S. Ho, Jennifer E. PLoS One Research Article BACKGROUND: Men are at higher risk for serious complications related to COVID-19 infection than women. More robust immune activation in women has been proposed to contribute to decreased disease severity, although systemic inflammation has been associated with worse outcomes in COVID-19 infection. Whether systemic inflammation contributes to sex differences in COVID-19 infection is not known. STUDY DESIGN AND METHODS: We examined sex differences in inflammatory markers among 453 men (mean age 61) and 328 women (mean age 62) hospitalized with COVID-19 infection at the Massachusetts General Hospital from March 8 to April 27, 2020. Multivariable linear regression models were used to examine the association of sex with initial and peak inflammatory markers. Exploratory analyses examined the association of sex and inflammatory markers with 28-day clinical outcomes using multivariable logistic regression. RESULTS: Initial and peak CRP were higher in men compared with women after adjustment for baseline differences (initial CRP: ß 0.29, SE 0.07, p = 0.0001; peak CRP: ß 0.31, SE 0.07, p<0.0001) with similar findings for IL-6, PCT, and ferritin (p<0.05 for all). Men had greater than 1.5-greater odds of dying compared with women (OR 1.71, 95% CI 1.04–2.80, p = 0.03). Sex modified the association of peak CRP with both death and ICU admission, with stronger associations observed in men compared with women (death: OR 9.19, 95% CI 4.29–19.7, p <0.0001 in men vs OR 2.81, 95% CI 1.52–5.18, p = 0.009 in women, P(interaction) = 0.02). CONCLUSIONS: In a sample of 781 men and women hospitalized with COVID-19 infection, men exhibited more robust inflammatory activation as evidenced by higher initial and peak inflammatory markers, as well as worse clinical outcomes. Better understanding of sex differences in immune responses to COVID-19 infection may shed light on the pathophysiology of COVID-19 infection. Public Library of Science 2021-04-28 /pmc/articles/PMC8081177/ /pubmed/33909684 http://dx.doi.org/10.1371/journal.pone.0250774 Text en © 2021 Lau et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lau, Emily S.
McNeill, Jenna N.
Paniagua, Samantha M.
Liu, Elizabeth E.
Wang, Jessica K.
Bassett, Ingrid V.
Selvaggi, Caitlin A.
Lubitz, Steven A.
Foulkes, Andrea S.
Ho, Jennifer E.
Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
title Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
title_full Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
title_fullStr Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
title_full_unstemmed Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
title_short Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
title_sort sex differences in inflammatory markers in patients hospitalized with covid-19 infection: insights from the mgh covid-19 patient registry
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081177/
https://www.ncbi.nlm.nih.gov/pubmed/33909684
http://dx.doi.org/10.1371/journal.pone.0250774
work_keys_str_mv AT lauemilys sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT mcneilljennan sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT paniaguasamantham sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT liuelizabethe sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT wangjessicak sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT bassettingridv sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT selvaggicaitlina sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT lubitzstevena sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT foulkesandreas sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry
AT hojennifere sexdifferencesininflammatorymarkersinpatientshospitalizedwithcovid19infectioninsightsfromthemghcovid19patientregistry